{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:19:00Z","timestamp":1790047140556,"version":"4.0.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008721","name":"UCLH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"NIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014461","name":"Biomedical Research Centre","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014461","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["088208"],"award-info":[{"award-number":["088208"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["305823"],"award-info":[{"award-number":["305823"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"European Union Seventh Framework Programme","doi-asserted-by":"publisher","award":["FP7\/2007\u20132013"],"award-info":[{"award-number":["FP7\/2007\u20132013"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research (NIHR)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008721","name":"University College London Hospitals (UCLH)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014461","name":"Biomedical Research Centre","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014461","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["HD084096"],"award-info":[{"award-number":["HD084096"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.placenta.2017.09.011","type":"journal-article","created":{"date-parts":[[2017,9,28]],"date-time":"2017-09-28T00:45:13Z","timestamp":1506559513000},"page":"S44-S50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"S1","title":["Maternal uterine artery VEGF gene therapy for treatment of intrauterine growth restriction"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0199-6140","authenticated-orcid":false,"given":"Anna L.","family":"David","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.placenta.2017.09.011_bib1","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S0140-6736(10)62233-7","article-title":"Major risk factors for stillbirth in high-income countries: a systematic review and meta-analysis","volume":"377","author":"Flenady","year":"2011","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.placenta.2017.09.011_bib2","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/HYPERTENSIONAHA.113.01892","article-title":"Spiral artery remodeling and trophoblast invasion in preeclampsia and fetal growth restriction relationship to clinical outcome","volume":"62","author":"Lyall","year":"2013","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.placenta.2017.09.011_bib3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1471-0528.2003.t01-1-02163.x","article-title":"Longitudinal quantification of uterine artery blood volume flow changes during gestation in pregnancies complicated by intrauterine growth restriction","volume":"110","author":"Konje","year":"2003","journal-title":"BJOG An Int J Obstet Gynaecol"},{"issue":"6","key":"10.1016\/j.placenta.2017.09.011_bib4","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.ajog.2006.03.065","article-title":"Maternal serum concentration of soluble fms-like tyrosine kinase 1 and vascular endothelial growth factor in women with abnormal uterine artery Doppler and in those with fetal growth restriction","volume":"195","author":"Savvidou","year":"2006","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"7","key":"10.1016\/j.placenta.2017.09.011_bib5","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.placenta.2017.09.011_bib6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.placenta.2017.02.011","article-title":"Placental soluble fms-like tyrosine kinase expression in small for gestational age infants and risk for adverse outcomes","volume":"52","author":"Spiel","year":"2017","journal-title":"Placenta"},{"issue":"93","key":"10.1016\/j.placenta.2017.09.011_bib7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1210\/jc.2007-1042","article-title":"Placental expression of soluble fms-like tyrosine kinase 1 is increased in singletons and twin pregnancies with intrauterine growth restriction","volume":"2017","author":"Nevo","year":"2008","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.placenta.2017.09.011_bib8","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/pd.4401","article-title":"Treatment of poor placentation and the prevention of associated adverse outcomes\u2013what does the future hold?","volume":"34","author":"Spencer","year":"2014","journal-title":"Prenat. Diagn"},{"issue":"1","key":"10.1016\/j.placenta.2017.09.011_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa041367","article-title":"EPICure Study Group. Neurologic and developmental disability at six years of age after extremely preterm birth","volume":"352","author":"Marlow","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.placenta.2017.09.011_bib10","article-title":"The investigation and management of the small \u2013 for \u2013 gestational \u2013 age fetus","author":"Royal College of Obstetricians and Gynaecologists","year":"2013","journal-title":"RCOG Green Top. Guidel."},{"issue":"2","key":"10.1016\/j.placenta.2017.09.011_bib11","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/01.AOG.0000253215.79121.75","article-title":"Predictors of neonatal outcome in early-onset placental dysfunction","volume":"109","author":"Baschat","year":"2007","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.placenta.2017.09.011_bib12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/jgm.2698","article-title":"Gene therapy clinical trials worldwide to 2012-an update","volume":"15","author":"Ginn","year":"2013","journal-title":"J.\u00a0Gene Med."},{"issue":"7","key":"10.1016\/j.placenta.2017.09.011_bib13","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/pd.2787","article-title":"Organ targeted prenatal gene therapy\u2014how far are we?","volume":"31","author":"Mehta","year":"2011","journal-title":"Prenat. Diagn"},{"issue":"4","key":"10.1016\/j.placenta.2017.09.011_bib14","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/uog.15880","article-title":"Ethics and social acceptability of a proposed clinical trial using maternal gene therapy to treat severe early-onset fetal growth restriction","volume":"47","author":"Sheppard","year":"2016","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.placenta.2017.09.011_bib15","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1210\/jc.2004-1052","article-title":"Adenovirally mediated expression of insulin-like growth factors enhances the function of first trimester placental fibroblasts","volume":"90","author":"Miller","year":"2005","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.placenta.2017.09.011_bib16","doi-asserted-by":"crossref","first-page":"e0140879","DOI":"10.1371\/journal.pone.0140879","article-title":"Development of non-viral, trophoblast-specific gene delivery for placental therapy","volume":"10","author":"Ellah","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.placenta.2017.09.011_bib17","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1089\/hum.2014.065","article-title":"Intraplacental gene therapy with Ad-IGF-1 corrects naturally occurring rabbit model of intrauterine growth restriction","volume":"26","author":"Keswani","year":"2015","journal-title":"Hum. Gene Ther."},{"issue":"2","key":"10.1016\/j.placenta.2017.09.011_bib18","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.placenta.2013.11.012","article-title":"Regulation of amino acid transporters by adenoviral-mediated human insulin-like growth factor-1 in a mouse model of placental insufficiency in\u00a0vivo and the human trophoblast line BeWo in\u00a0vitro","volume":"35","author":"Jones","year":"2014","journal-title":"Placenta"},{"issue":"9","key":"10.1016\/j.placenta.2017.09.011_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074632","article-title":"Adenoviral-mediated placental gene transfer of IGF-1 corrects placental insufficiency via enhanced placental glucose transport mechanisms","volume":"8","author":"Jones","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.placenta.2017.09.011_bib20","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/gt.2008.102","article-title":"Local delivery of VEGF adenovirus to the uterine artery increases vasorelaxation and uterine blood flow in the pregnant sheep","volume":"15","author":"David","year":"2008","journal-title":"Gene Ther."},{"key":"10.1016\/j.placenta.2017.09.011_bib21","first-page":"86","article-title":"Long-term increase in uterine blood flow is achieved by local overexpression of VEGF-A(165) in the uterine arteries of pregnant sheep","author":"Mehta","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.placenta.2017.09.011_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100021","article-title":"Local over-expression of VEGF-D\u0394N\u0394Cin the uterine arteries of pregnant sheep results in long-term changes in uterine artery contractility and angiogenesis","volume":"9","author":"Mehta","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.placenta.2017.09.011_bib23","article-title":"Maternal uterine artery gene therapy with Ad.VEGF-A165 increases weight at term in a Guinea pig model of fetal growth restriction","volume":"26","author":"Swanson","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.placenta.2017.09.011_bib24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1089\/hum.2013.214","article-title":"Uteroplacental adenovirus vascular endothelial growth factor gene therapy increases fetal growth velocity in growth-restricted sheep pregnancies","volume":"25","author":"Carr","year":"2014","journal-title":"Hum. Gene Ther."},{"issue":"6","key":"10.1016\/j.placenta.2017.09.011_bib25","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1095\/biolreprod.115.133744","article-title":"Peri- and postnatal effects of prenatal adenoviral VEGF gene therapy in growth-restricted sheep","volume":"94","author":"Carr","year":"2016","journal-title":"Biol. Reprod."},{"issue":"4","key":"10.1016\/j.placenta.2017.09.011_bib26","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2174\/156652311796150363","article-title":"Advances and future challenges in adenoviral vector pharmacology and targeting","volume":"11","author":"Khare","year":"2011","journal-title":"Curr. Gene Ther."},{"issue":"10","key":"10.1016\/j.placenta.2017.09.011_bib27","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1161\/01.CIR.96.10.3561","article-title":"In utero cardiac gene transfer via intraplacental delivery of recombinant adenovirus","volume":"96","author":"Woo","year":"1997","journal-title":"Circulation"},{"issue":"Suppl.1","key":"10.1016\/j.placenta.2017.09.011_bib28","article-title":"Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen - a review","volume":"21","author":"Ahmed","year":"2000","journal-title":"Placenta"},{"issue":"2 Pt 1","key":"10.1016\/j.placenta.2017.09.011_bib29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/AOG.0000000000000367","article-title":"Characterization of the soluble fms-like tyrosine Kinase-1 to placental growth factor ratio in pregnancies complicated by fetal growth restriction","volume":"124","author":"Herraiz","year":"2014","journal-title":"Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.placenta.2017.09.011_bib30","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/gt.2012.17","article-title":"VEGF gene therapy: therapeutic angiogenesis in the clinic and beyond","volume":"19","author":"Giacca","year":"2012","journal-title":"Gene Ther."},{"issue":"5","key":"10.1016\/j.placenta.2017.09.011_bib31","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1242\/bio.017434","article-title":"VEGF-A isoforms program differential VEGFR2 signal transduction, trafficking and proteolysis","volume":"5","author":"Fearnley","year":"2016","journal-title":"Biol. Open"},{"issue":"9","key":"10.1016\/j.placenta.2017.09.011_bib32","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1182\/blood-2007-12-125856","article-title":"Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization","volume":"112","author":"Kawamura","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.placenta.2017.09.011_bib33","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.placenta.2005.12.002","article-title":"Nutritional modulation of adolescent pregnancy outcome - a review","volume":"27","author":"Wallace","year":"2006","journal-title":"Placenta"},{"issue":"2","key":"10.1016\/j.placenta.2017.09.011_bib34","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ajog.2012.05.008","article-title":"Fetoplacental biometry and umbilical artery Doppler velocimetry in the overnourished adolescent model of fetal growth restriction","volume":"207","author":"Carr","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.placenta.2017.09.011_bib35","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.placenta.2015.03.003","article-title":"Animal models of fetal growth restriction: considerations for translational medicine","volume":"36","author":"Swanson","year":"2015","journal-title":"Placenta"},{"issue":"2","key":"10.1016\/j.placenta.2017.09.011_bib36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/0023677216637506","article-title":"The use of ultrasound to assess fetal growth in a Guinea pig model of fetal growth restriction","volume":"51","author":"Swanson","year":"2017","journal-title":"Lab. Anim."},{"key":"10.1016\/j.placenta.2017.09.011_bib37","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1177\/1933719116630411","article-title":"Gene targeting to the uteroplacental circulation of pregnant Guinea pigs","volume":"3","author":"Mehta","year":"2016","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.placenta.2017.09.011_bib38","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1089\/hum.2016.046","article-title":"Maternal therapy with Ad.VEGF-A165 increases fetal weight at term in a Guinea pig model of fetal growth restriction","volume":"27","author":"Swanson","year":"2016","journal-title":"Hum. Gene Ther."},{"issue":"11","key":"10.1016\/j.placenta.2017.09.011_bib39","doi-asserted-by":"crossref","first-page":"R796","DOI":"10.1152\/ajpregu.00544.2013","article-title":"Methodological differences account for inconsistencies in reported free VEGF concentrations in pregnant rats","volume":"306","author":"Weissgerber","year":"2014","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"11","key":"10.1016\/j.placenta.2017.09.011_bib40","first-page":"A60","article-title":"Human placental ex\u00a0vivo studies to support an adenovirus-mediated vascular endothelial growth factor (VEGF) gene medicine for the treatment of severe early onset fetal growth restriction","volume":"25","author":"Brownbill","year":"2014","journal-title":"Hum. Gene Ther."},{"issue":"4","key":"10.1016\/j.placenta.2017.09.011_bib41","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s00270-011-0166-2","article-title":"Perioperative temporary occlusion of the internal iliac arteries as prophylaxis in cesarean section at risk of hemorrhage in placenta accreta","volume":"34","author":"Carnevale","year":"2011","journal-title":"Cardiovasc Interv. Radiol."},{"issue":"10","key":"10.1016\/j.placenta.2017.09.011_bib42","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/sj.gt.3301444","article-title":"Angiographically guided utero-placental gene transfer in rabbits with adenoviruses, plasmid\/liposomes and plasmid\/polyethyleneimine complexes","volume":"8","author":"Heikkil\u00e4","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.placenta.2017.09.011_bib43","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/humc.2015.2518","article-title":"Gene therapy and gene transfer projects of the 7th Framework Programme for research and technological development of the European Union","volume":"26","author":"Gancberg","year":"2015","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.placenta.2017.09.011_bib44","first-page":"A98","article-title":"Ethics and ethical evaluation of a proposed clinical trial with maternal uterine artery vascular endothelial growth factor gene therapy to treat severe early onset fetal growth restriction in pregnant","volume":"25","author":"Sheppard","year":"2014","journal-title":"Hum. Gene Ther."},{"issue":"1","key":"10.1016\/j.placenta.2017.09.011_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2008.08.029","article-title":"The effects of sildenafil citrate (Viagra) on uterine blood flow and well being in the intrauterine growth-restricted fetus","volume":"200","author":"Miller","year":"2009","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2017.09.011_bib46","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1080\/00016340601089875","article-title":"Lower uterine blood supply: extrauterine anastomotic system and its application in surgical devascularization techniques","volume":"86","author":"Jaraquemada","year":"2007","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.placenta.2017.09.011_bib47","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1148\/radiology.208.2.9680559","article-title":"Life-threatening primary postpartum hemorrhage: treatment with emergency selective arterial embolization","volume":"208","author":"Pelage","year":"1998","journal-title":"Radiology"},{"key":"10.1016\/j.placenta.2017.09.011_bib48","series-title":"Postpartum Haemorrhage","first-page":"177","article-title":"Hemodynamic changes in the uterus and its blood vessels in pregnancy * \u2020","author":"Burbank","year":"2009"},{"key":"10.1016\/j.placenta.2017.09.011_bib49","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/gt.2009.4","article-title":"Eight-year safety follow-up of coronary artery disease patients after local intracoronary VEGF gene transfer","volume":"16","author":"Hedman","year":"2009","journal-title":"Gene Ther."},{"issue":"4","key":"10.1016\/j.placenta.2017.09.011_bib50","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/gt.2011.109","article-title":"10-year safety follow-up in patients with local VEGF gene transfer to ischemic lower limb","volume":"19","author":"Muona","year":"2012","journal-title":"Gene Ther."},{"issue":"1","key":"10.1016\/j.placenta.2017.09.011_bib51","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12884-017-1226-7","article-title":"EVERREST prospective study: a 6-year prospective study to define the clinical and biological characteristics of pregnancies affected by severe early onset fetal growth restriction. BMC Pregnancy Childbirth","volume":"17","author":"Spencer","year":"2017","journal-title":"BMC Pregnancy Childbirth"},{"issue":"1","key":"10.1016\/j.placenta.2017.09.011_bib52","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1515\/jpm-2013-0074","article-title":"The importance of repeated measurements of the sFlt-1\/PlGF ratio for the prediction of preeclampsia and intrauterine growth restriction","volume":"42","author":"Schoofs","year":"2014","journal-title":"J.\u00a0Perinat. Med."}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400417311256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400417311256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:56:35Z","timestamp":1758909395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400417311256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":52,"alternative-id":["S0143400417311256"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2017.09.011","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maternal uterine artery VEGF gene therapy for treatment of intrauterine growth restriction","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2017.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 IFPA and Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}